NFA
IRWD icon

Nationwide Fund Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Nationwide Fund Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-343,719
Closed -$4.54M – 1030
2017
Q3 		$4.54M Buy
343,719
+8,929
+3% +$123K 0.02% 1062
2017
Q2 		$5.29M Buy
334,790
+60,550
+22% +$880K 0.02% 982
2017
Q1 		$3.92M Buy
274,240
+142,693
+108% +$1.95M 0.02% 1099
2016
Q4 		$1.69M Sell
131,547
-4,648
-3% -$58.7K 0.01% 1488
2016
Q3 		$1.81M Hold
136,195
– – 0.01% 1439
2016
Q2 		$1.49M Buy
136,195
+3,604
+3% +$35.2K 0.01% 1510
2016
Q1 		$1.22M Sell
132,591
-1,513
-1% -$12.5K 0.01% 1607
2015
Q4 		$1.3M Buy
134,104
+2,210
+2% +$21.4K 0.01% 1587
2015
Q3 		$1.15M Hold
131,894
– – 0.01% 1659
2015
Q2 		$1.33M Sell
131,894
-21,342
-14% -$248K 0.01% 1688
2015
Q1 		$2.05M Sell
153,236
-4,042
-3% -$53K 0.01% 1457
2014
Q4 		$2.02M Sell
157,278
-1,278
-0.8% -$14.6K 0.01% 1406
2014
Q3 		$1.72M Buy
158,556
+289
+0.2% +$3.31K 0.01% 1524
2014
Q2 		$2.03M Buy
158,267
+11,637
+8% +$127K 0.01% 1462
2014
Q1 		$1.51M Buy
146,630
+18,633
+15% +$210K 0.01% 1534
2013
Q4 		$1.25M Sell
127,997
-2,357
-2% -$21.2K 0.01% 1747
2013
Q3 		$1.29M Buy
130,354
+9,237
+8% +$90.6K 0.01% 1706
2013
Q2 		$1.01M Buy
+121,117
New +$1.47M 0.01% 1675

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nationwide Fund Advisors's IRWD Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2017, closing a stake of 343,719 shares — an estimated $4.54M sold.

Nationwide Fund Advisors first reported a position in IRWD in Q2 2013 and held it in 18 quarters. The position peaked at $5.29M in Q2 2017. 158 funds tracked by Wall St. Rank hold IRWD as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Ironwood Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 343,719 Ironwood Pharmaceuticals shares in Q4 2017, an estimated $4.54M.
  • Nationwide Fund Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Ironwood Pharmaceuticals position peaked at $5.29M in Q2 2017.
  • 158 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.